Ex vivo studies explain disappointing results with antiadhesion therapy in stroke patients Feb. 8, 1999
Second-generation NNRTIs show promising resistance profile, pharmacokinetics in preclinical studies Feb. 8, 1999
AIDS conference serves as forum for highlighting new Vertex/Glaxo Wellcome HIV protease inhibitor Feb. 5, 1999